Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Eibisberger, M; Resch, E; Resch, B.
Surfactant replacement therapy in extremely low gestational age newborns.
Indian Pediatr. 2015; 52(3):227-230
Doi: 10.1007/s13312-015-0612-3
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
-
Eibisberger Monika
-
Resch Bernhard
- Co-Autor*innen der Med Uni Graz
-
Resch-Poteralski Elisabeth
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
-
There is a growing body of evidence over the last years suggesting continuous positive airway pressure (CPAP) ventilation being the first choice of ventilatory support in newborns with extremely low gestational age, and early rescue surfactant treatment being as effective as prophylactic therapy. The Intubation Surfactant Extubation procedure is discussed as an alternative procedure that may have the potential to combine the positive effects of surfactant and early CPAP. A further mode of surfactant administration, administration via a thin endotracheal catheter during spontaneous breathing with CPAP, has recently come into clinical use. This less invasive surfactant administration technique shows some short-term benefits but still cannot be recommended for general use in this vulnerable population. Long-term follow-up studies are needed to allow new recommendations on surfactant therapy in this high-risk population.
- Find related publications in this database (using NLM MeSH Indexing)
-
Continuous Positive Airway Pressure - methods
-
Humans -
-
Infant, Extremely Premature - physiology
-
Infant, Newborn -
-
Pulmonary Surfactants - therapeutic use
-
Respiratory Distress Syndrome, Newborn - drug therapy
-
Respiratory Distress Syndrome, Newborn - prevention & control
- Find related publications in this database (Keywords)
-
Low birth weight
-
Prematurity
-
Respiratory distress syndrome